Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Patients With Intermittent Claudication Injected With ALDH Bright Cells (PACE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by The University of Texas Health Science Center, Houston
Sponsor:
Collaborators:
Aldagen
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT01774097
First received: January 18, 2013
Last updated: November 3, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)